Pricing Log in Create free account
Friday 6 November 2026 Export VTRS’s income statement to Excel — free account

Viatris Inc.

VTRS Healthcare Drug Manufacturers Specialty & Generic

Viatris Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, down 2.98% from fiscal 2024.

Revenue
−0.28%
EPS
−154.6%
Free cash flow
+38.8%
Total debt
−89.4%

Quarter to September 2026, against a year earlier

19.69 0.72 +3.80%
Market cap
$21.8B
P/E
0.0×
Fwd P/E
82.6×
Dividend yield
2.54%
F-score
4/9
Altman Z
0.61
Beneish M
−3.29
Dividend safety
37/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Valuation Filings

Viatris Inc. 8-K filed Nov 5, 2026

Period ended Nov 5, 2026 · Filed · accepted 7:45 AM ET · Document on sec.gov · Filing index

2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits

This 8-K released the latest quarter’s results. Read Earnings & Analysis